We are live on
!
Find out more
WG
Wealth Group Portfolio holdings
AUM
$401M
This Fund
S&P 500
This Quarter
Est. Return
+1.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$155M
AUM Growth
+$5.58M
(+3.7%)
Cap. Flow
+$5.19M
Cap. Flow
% of AUM
3.36%
Top 10 Holdings %
Top 10 Hldgs %
39.34%
Holding
164
New
12
Increased
84
Reduced
54
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$480K |
| 2 |
Bristol-Myers Squibb
BMY
|
+$336K |
| 3 |
SCHV
Schwab US Large-Cap Value ETF
SCHV
|
+$331K |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$323K |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$323K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
+$407K |
| 2 |
Wayfair
W
|
+$241K |
| 3 |
Archer Daniels Midland
ADM
|
+$236K |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$234K |
| 5 |
TBIL
F/m US Treasury 3 Month Bill Fund
TBIL
|
+$175K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.3% |
| 2 | Consumer Discretionary | 11.61% |
| 3 | Consumer Staples | 10.64% |
| 4 | Financials | 9.94% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
HCA Healthcare
HCA
$84.8B
| $214K | 0.14% |
714
-25
| -3% | -$8.74K |
|
152
Morgan Stanley
MS
$337B
| $214K | 0.14% |
+1,704
| New | +$210K |
|
153
AllianzIM U.S. Equity Buffer20 Apr ETF
APRW
$200M
| $212K | 0.14% |
6,467
| – | – |
|
154
Ares Capital
ARCC
$13.5B
| $207K | 0.13% |
+9,452
| New | +$204K |
|
155
iShares Gold Trust
IAU
$63B
| $207K | 0.13% |
+4,183
| New | +$210K |
|
156
ConocoPhillips
COP
$147B
| $205K | 0.13% |
2,065
+85
| +4% | +$9.03K |
|
157
Ford
F
$57.3B
| $109K | 0.07% |
+10,962
| New | +$117K |
|
158
Coherus Oncology
CHRS
$217M
| $72K | 0.05% |
52,195
| – | – |
|
159
PDS Biotechnology
PDSB
$38.1M
| $25K | 0.02% |
15,399
| – | – |
|
160
Purple Innovation
PRPL
$33.2M
| $8K | 0.01% |
400
| – | – |
|
|
161
Archer Daniels Midland
ADM
$41.4B
| – | – |
-3,943
| Closed | -$236K |
|
|
162
Regeneron Pharmaceuticals
REGN
$68.8B
| – | – |
-223
| Closed | -$234K |
|
|
163
Wayfair
W
$11.1B
| – | – |
-4,294
| Closed | -$241K |
|
|
IBDP
164
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| – | – |
-16,159
| Closed | -$407K |
|
Similar funds
AIM
SFCL
TGV
BLC
JGCM
BWA
DBIA
P8IP
Wealth Group's Q4 2024 Portfolio in Review
As of Q4 2024, Wealth Group held 164 positions worth $155M, up 3.7% from $149M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Wealth Group deployed $5.19M of net new capital in Q4 2024, opening 12 new positions and adding to 84 existing holdings. Its largest new stake was Bristol-Myers Squibb: 6,015 shares worth $340K.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was F/m US Treasury 3 Month Bill Fund, an estimated $175K trimmed.
- Wealth Group's largest Q4 2024 buy was Bristol-Myers Squibb: 6,015 shares worth $340K.
- Wealth Group added most to Vanguard Total Bond Market in Q4 2024, an estimated $480K increase.
- Wealth Group's biggest Q4 2024 reduction was F/m US Treasury 3 Month Bill Fund, cutting an estimated $175K.
- Wealth Group fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $407K.
- Wealth Group's ten largest holdings make up 39% of its $155M portfolio in Q4 2024.
- Wealth Group opened 12 new positions and closed 4 in Q4 2024.
- Wealth Group's portfolio value rose 3.7% quarter-over-quarter to $155M.
Based on Wealth Group's 13F filing for Q4 2024, filed 6 Feb 2025.